DOSSIERS / SANOFI DEVELOPPEMENT PHARMA
← SearchExport PDF
Company dossier

SANOFI DEVELOPPEMENT PHARMA

FRANCE · COMPANY · INCORPORATED 1995-06-19
KYBE ID: FR-401393624 · 401393624 · 2 sources
RISK SCORE22LOW RISK
OverviewOwnershipPeopleRisk signals 2Sources

Key facts

dissolved
SANOFI DEVELOPPEMENT PHARMA
fr_inpi
401393624
fr_inpi
dissolved
fr_inpi
Simplified joint-stock company (SAS)
fr_inpi
1995-06-19
fr_inpi
82 AV RASPAIL, 94250 GENTILLY
fr_inpi
€1,900,000
fr_inpi

Ownership structure

1 entities

No ownership links on record for this entity.

Companies at this address

25 total
AVENTIS AGRICULTUREactiveAVENTIS PHARMA EURLactiveBIOCITECH SASdissolvedGROUPEMENT DE FABRICATION PHARMACEUTIQUEdissolvedKIADIS PHARMA FRANCEdissolvedLUGAN ET CIEdissolvedSANOFI 2015 CdissolvedSANOFI 2015 DdissolvedSANOFI 2018 AdissolvedSANOFI 2020 AdissolvedSANOFI 2020 CdissolvedSANOFI 2020 DdissolvedSANOFI-AVENTIS FRANCEdissolvedSANOFI-AVENTIS GROUPEactiveSANOFI AVENTIS PARTICIPATIONSactiveSANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENTdissolvedSANOFI BIOTECHNOLOGYdissolvedSANOFI CHIMIEdissolvedSANOFI DEVELOPPEMENTdissolvedSANOFI MATURE IPdissolved

+5 more

People with significant control

3 people
NameRoleFromSource
ERIC DANIEL VACARESSEDirecteur général délégué—France registry
PAULINE PEREIRADirecteur général délégué—France registry
Isabelle Cécile Thérèse COMOLETPrésident du conseil d'administration—France registry

Risk signals

2 matched
low

Clustered address

Address shared by 25 companies

high

Business fragmentation

A director is shared across 10 companies — business-splitting (дробление) pattern

Risk journey — why 22?

2 signals
+16
Business fragmentation
+6
Clustered address
Composite risk score22/100